Schedule 13D ownership disclosure

WEREWOLF THERAPEUTICS INC

Security class unavailable · CUSIP: 95075A107

Event date: 2024-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,179,035
Percent of class
15.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-024061
Form type
SC 13D/A
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Feb 14, 2024
Reporting period
Feb 12, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub